Schwab, C. L., Bellone, S., English, D. P., Roque, D. M., Lopez, S., Cocco, E., . . . Santin, A. D. (2014). Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo. Br J Cancer.
Styl ChicagoSchwab, C L., et al. "Afatinib Demonstrates Remarkable Activity against HER2-amplified Uterine Serous Endometrial Cancer in Vitro and in Vivo." Br J Cancer 2014.
Citace podle MLASchwab, C L., et al. "Afatinib Demonstrates Remarkable Activity against HER2-amplified Uterine Serous Endometrial Cancer in Vitro and in Vivo." Br J Cancer 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..